Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 29, 2017 Filed Mar 31, 2017 20:08 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
Exercise / conversionCommon Stock | 13,750 | $73.51 | $1,010,762.50 |
DisclosureSEC source: 0001209191-17-023840 · doc4.xml · nonDerivative · entry 1 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:09 UTC |
Sachdev AmitEVP, CRO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 28,593 | $45.11 Strike: $45.11 | $1,289,830.23 |
DisclosureSEC source: 0001209191-17-023841 · doc4.xml · derivative · entry 11 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,593 shares Expires 2023-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:09 UTC |
Sachdev AmitEVP, CRO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 29,032 | $48.74 Strike: $48.74 | $1,415,019.68 |
DisclosureSEC source: 0001209191-17-023841 · doc4.xml · derivative · entry 10 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,032 shares Expires 2022-07-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:09 UTC |
Sachdev AmitEVP, CRO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,156 | $37.86 Strike: $37.86 | $649,526.16 |
DisclosureSEC source: 0001209191-17-023841 · doc4.xml · derivative · entry 9 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,156 shares Expires 2022-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:09 UTC |
Sachdev AmitEVP, CRO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,719 | $38.80 Strike: $38.80 | $221,897.20 |
DisclosureSEC source: 0001209191-17-023841 · doc4.xml · derivative · entry 8 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,719 shares Expires 2021-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:09 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 29,032 | $110.00 | $3,193,520.00 |
DisclosureSEC source: 0001209191-17-023841 · doc4.xml · nonDerivative · entry 6 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,335 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:09 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 51,468 | $106.30 | $5,471,048.40 |
DisclosureSEC source: 0001209191-17-023841 · doc4.xml · nonDerivative · entry 5 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,367 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:09 UTC |
Sachdev AmitEVP, CRO
|
Exercise / conversionCommon Stock | 28,593 | $45.11 | $1,289,830.23 |
DisclosureSEC source: 0001209191-17-023841 · doc4.xml · nonDerivative · entry 4 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,835 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:09 UTC |
Sachdev AmitEVP, CRO
|
Exercise / conversionCommon Stock | 29,032 | $48.74 | $1,415,019.68 |
DisclosureSEC source: 0001209191-17-023841 · doc4.xml · nonDerivative · entry 3 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:09 UTC |
Sachdev AmitEVP, CRO
|
Exercise / conversionCommon Stock | 17,156 | $37.86 | $649,526.16 |
DisclosureSEC source: 0001209191-17-023841 · doc4.xml · nonDerivative · entry 2 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,210 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:09 UTC |
Sachdev AmitEVP, CRO
|
Exercise / conversionCommon Stock | 5,719 | $38.80 | $221,897.20 |
DisclosureSEC source: 0001209191-17-023841 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,054 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:09 UTC |
Silva Paul MSVP & Corp Controller
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,688 | $0.00 Strike: $45.11 | $0.00 |
DisclosureSEC source: 0001209191-17-023842 · doc4.xml · derivative · entry 4 Silva Paul M · CIK 0001446372 · SVP & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,438 Underlying: Common Stock · 1,688 shares Expires 2023-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:09 UTC |
Silva Paul MSVP & Corp Controller
|
SaleCommon Stock | 1,688 | $106.30 | $179,434.40 |
DisclosureSEC source: 0001209191-17-023842 · doc4.xml · nonDerivative · entry 2 Silva Paul M · CIK 0001446372 · SVP & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,071 F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 20:09 UTC |
Silva Paul MSVP & Corp Controller
|
Exercise / conversionCommon Stock | 1,688 | $45.11 | $76,145.68 |
DisclosureSEC source: 0001209191-17-023842 · doc4.xml · nonDerivative · entry 1 Silva Paul M · CIK 0001446372 · SVP & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:15 UTC |
SMITH IAN FEVP, CFO & COO
|
SaleCommon Stock | 3,842 | $90.00 | $345,780.00 |
DisclosureSEC source: 0001209191-17-016546 · doc4.xml · nonDerivative · entry 1 SMITH IAN F · CIK 0001197032 · EVP, CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,238 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:41 UTC |
SMITH IAN FEVP, CFO & COO
|
SaleCommon Stock | 3,842 | $87.66 | $336,789.72 |
DisclosureSEC source: 0001209191-17-011104 · doc4.xml · nonDerivative · entry 1 SMITH IAN F · CIK 0001197032 · EVP, CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,080 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $87.66 (range $87.30 to $88.22). Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:42 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 5,122 | $87.67 | $449,045.74 |
DisclosureSEC source: 0001209191-17-011107 · doc4.xml · nonDerivative · entry 1 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,511 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $87.67 (range $87.30 to $88.22). Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:45 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 100 | $88.39 | $8,839.00 |
DisclosureSEC source: 0001209191-17-011115 · doc4.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,645 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:45 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
SaleCommon Stock | 23,804 | $87.68 | $2,087,134.72 |
DisclosureSEC source: 0001209191-17-011115 · doc4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,745 F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $87.68 (range $87.29 to $88.23). Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:43 UTC |
Sachdev AmitEVP, CRO
|
SaleCommon Stock | 7,684 | $87.68 | $673,733.12 |
DisclosureSEC source: 0001209191-17-011110 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,335 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $87.68 (range $87.30 to $88.18). F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:46 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 6,403 | $87.68 | $561,415.04 |
DisclosureSEC source: 0001209191-17-011119 · doc4.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,011 F1 · kind: Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $87.68 (range $87.29 to $88.23). F3 · price: Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:47 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
SaleCommon Stock | 3,792 | $88.39 | $335,174.88 |
DisclosureSEC source: 0001209191-17-011124 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,455 F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:45 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
GrantStock Option (Right to Buy) · Derivative | 103,550 | $0.00 Strike: $86.52 | $0.00 |
DisclosureSEC source: 0001209191-17-008377 · doc4.xml · derivative · entry 4 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,550 Underlying: Common Stock · 103,550 shares Expires 2027-02-02 F3 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/03/2017. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:45 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
GrantCommon Stock | 50,567 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-008377 · doc4.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,549 F2 · shares: Restricted stock unit award that vests in three equal installments on 2/10/2018, 2/10/2019 and 2/10/2020. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:45 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
GrantCommon Stock | 17,895 | $0.01 | $178.95 |
DisclosureSEC source: 0001209191-17-008377 · doc4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,982 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 2/02/2016 that contained both performance-vesting and service-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/03/2017. The earned performance shares remain subject to the service-vesting requirements and will vest in three equal installments on 2/10/2017, 2/10/2018 and 2/10/2019. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:47 UTC |
SMITH IAN FEVP, CFO & COO
|
GrantStock Option (Right to Buy) · Derivative | 31,065 | $0.00 Strike: $86.52 | $0.00 |
DisclosureSEC source: 0001209191-17-008383 · doc4.xml · derivative · entry 4 SMITH IAN F · CIK 0001197032 · EVP, CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,065 Underlying: Common Stock · 31,065 shares Expires 2027-02-02 F3 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/03/2017. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:47 UTC |
SMITH IAN FEVP, CFO & COO
|
GrantCommon Stock | 15,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-008383 · doc4.xml · nonDerivative · entry 2 SMITH IAN F · CIK 0001197032 · EVP, CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,922 F2 · shares: Restricted stock unit award that vests in three equal installments on 2/10/2018, 2/10/2019 and 2/10/2020. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:47 UTC |
SMITH IAN FEVP, CFO & COO
|
GrantCommon Stock | 5,753 | $0.01 | $57.53 |
DisclosureSEC source: 0001209191-17-008383 · doc4.xml · nonDerivative · entry 1 SMITH IAN F · CIK 0001197032 · EVP, CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,752 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 2/02/2016 that contained both performance-vesting and service-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/03/2017. The earned performance shares remain subject to the service-vesting requirements and will vest in three equal installments on 2/10/2017, 2/10/2018 and 2/10/2019. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:49 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
GrantStock Option (Right to Buy) · Derivative | 24,852 | $0.00 Strike: $86.52 | $0.00 |
DisclosureSEC source: 0001209191-17-008388 · doc4.xml · derivative · entry 3 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,852 Underlying: Common Stock · 24,852 shares Expires 2027-02-02 F3 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/03/2017. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:49 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
GrantCommon Stock | 12,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-008388 · doc4.xml · nonDerivative · entry 2 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,633 F2 · shares: Restricted stock unit award that vests in three equal installments on 2/10/2018, 2/10/2019 and 2/10/2020. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:49 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
GrantCommon Stock | 4,794 | $0.01 | $47.94 |
DisclosureSEC source: 0001209191-17-008388 · doc4.xml · nonDerivative · entry 1 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,497 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 2/02/2016 that contained both performance-vesting and service-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/03/2017. The earned performance shares remain subject to the service-vesting requirements and will vest in three equal installments on 2/10/2017, 2/10/2018 and 2/10/2019. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:48 UTC |
Sachdev AmitEVP, CRO
|
GrantCommon Stock · Derivative | 31,065 | $0.00 Strike: $86.52 | $0.00 |
DisclosureSEC source: 0001209191-17-008386 · doc4.xml · derivative · entry 4 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,065 Underlying: Common Stock · 31,065 shares Expires 2027-02-02 F3 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/03/2017. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:48 UTC |
Sachdev AmitEVP, CRO
|
GrantCommon Stock | 15,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-008386 · doc4.xml · nonDerivative · entry 2 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,019 F2 · shares: Restricted stock unit award that vests in three equal installments on 2/10/2018, 2/10/2019 and 2/10/2020. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:48 UTC |
Sachdev AmitEVP, CRO
|
GrantCommon Stock | 5,753 | $0.01 | $57.53 |
DisclosureSEC source: 0001209191-17-008386 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP, CRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,849 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 2/02/2016 that contained both performance-vesting and service-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/03/2017. The earned performance shares remain subject to the service-vesting requirements and will vest in three equal installments on 2/10/2017, 2/10/2018 and 2/10/2019. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:50 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 24,852 | $0.00 Strike: $86.52 | $0.00 |
DisclosureSEC source: 0001209191-17-008389 · doc4.xml · derivative · entry 4 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,852 Underlying: Common Stock · 24,852 shares Expires 2027-02-02 F3 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/03/2017. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:50 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
GrantCommon Stock | 12,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-008389 · doc4.xml · nonDerivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,247 F2 · shares: Restricted stock unit award that vests in three equal installments on 2/10/2018, 2/10/2019 and 2/10/2020. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:50 UTC |
Arbuckle Stuart AEVP\Chief Commercial Officer
|
GrantCommon Stock | 5,753 | $0.01 | $57.53 |
DisclosureSEC source: 0001209191-17-008389 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,111 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 2/02/2016 that contained both performance-vesting and service-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/03/2017. The earned performance shares remain subject to the service-vesting requirements and will vest in three equal installments on 2/10/2017, 2/10/2018 and 2/10/2019. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:56 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
GrantStock Option (Right to Buy) · Derivative | 37,278 | $0.00 Strike: $86.52 | $0.00 |
DisclosureSEC source: 0001209191-17-008397 · doc4.xml · derivative · entry 3 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,278 Underlying: Common Stock · 37,278 shares Expires 2027-02-02 F3 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/03/2017. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:56 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
GrantCommon Stock | 18,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-008397 · doc4.xml · nonDerivative · entry 2 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,414 F2 · shares: Restricted stock unit award that vests in three equal installments on 2/10/2018, 2/10/2019 and 2/10/2020. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:56 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
GrantCommon Stock | 4,794 | $0.01 | $47.94 |
DisclosureSEC source: 0001209191-17-008397 · doc4.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,210 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 2/02/2016 that contained both performance-vesting and service-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/03/2017. The earned performance shares remain subject to the service-vesting requirements and will vest in three equal installments on 2/10/2017, 2/10/2018 and 2/10/2019. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:57 UTC |
Parini MichaelEVP, CL&AO
|
GrantStock Option (Right to Buy) · Derivative | 37,278 | $0.00 Strike: $86.52 | $0.00 |
DisclosureSEC source: 0001209191-17-008399 · doc4.xml · derivative · entry 2 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,278 Underlying: Common Stock · 37,278 shares Expires 2027-02-02 F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/03/2017. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:57 UTC |
Parini MichaelEVP, CL&AO
|
GrantCommon Stock | 18,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-008399 · doc4.xml · nonDerivative · entry 1 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,554 F1 · shares: Restricted stock unit award that vests in three equal installments on 2/10/2018, 2/10/2019 and 2/10/2020. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 22:01 UTC |
Silva Paul MSVP & Corp Controller
|
GrantStock Option (Right to Buy) · Derivative | 12,944 | $0.00 Strike: $86.52 | $0.00 |
DisclosureSEC source: 0001209191-17-008402 · doc4.xml · derivative · entry 3 Silva Paul M · CIK 0001446372 · SVP & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,944 Underlying: Common Stock · 12,944 shares Expires 2027-02-02 F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/03/2017. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 22:01 UTC |
Silva Paul MSVP & Corp Controller
|
GrantCommon Stock | 6,321 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-008402 · doc4.xml · nonDerivative · entry 1 Silva Paul M · CIK 0001446372 · SVP & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,071 F1 · shares: Restricted stock unit award that vests in three equal installments on 2/10/2018, 2/10/2019 and 2/10/2020. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 21:34 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 1,500 | $85.91 | $128,865.00 |
DisclosureSEC source: 0001209191-17-007627 · doc4.xml · nonDerivative · entry 2 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,703 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $85.91 (range $85.70 to $86.16). Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 21:34 UTC |
Chodakewitz JeffreyEVP GMDA, CMO
|
SaleCommon Stock | 400 | $85.08 | $34,032.00 |
DisclosureSEC source: 0001209191-17-007627 · doc4.xml · nonDerivative · entry 1 Chodakewitz Jeffrey · CIK 0001610876 · EVP GMDA, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,203 F1 · kind: Transaction made pursuant to Dr. Chodakewitz's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Chodakewitz undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $85.08 (range $84.67 to $85.44). Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 21:35 UTC |
Parini MichaelEVP, CLO & CAO
|
SaleCommon Stock | 3,450 | $85.98 | $296,631.00 |
DisclosureSEC source: 0001209191-17-007630 · doc4.xml · nonDerivative · entry 1 Parini Michael · CIK 0001661567 · EVP, CLO & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,350 F1 · kind: Transaction made pursuant to Mr. Parini's company approved trading plan under Rule 10b5-1. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 17:33 UTC |
SACHS BRUCE IDirector
|
GrantDeferred Stock Units · Derivative | 508.256 | $81.16 | $41,250.06 |
DisclosureSEC source: 0001209191-17-004375 · doc4.xml · derivative · entry 1 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,974.235 Underlying: Common Stock · 508.256 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. F1 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. F1 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. Read SEC document |
| January 11, 2017 Filed Jan 13, 2017 21:12 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $36.30 | $0.00 |
DisclosureSEC source: 0001209191-17-003660 · doc4.xml · derivative · entry 9 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires 2017-01-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Fully vested. Read SEC document |
| January 11, 2017 Filed Jan 13, 2017 21:12 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 500 | $84.98 | $42,490.00 |
DisclosureSEC source: 0001209191-17-003660 · doc4.xml · nonDerivative · entry 6 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,225 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $84.98 (range $84.87 to $85.11). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.